Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.57 is 40% above its 4-year average of -2.63, near the high end of its 4-year range (-3.82–-1.57).
20.91% above its 12-month average of -1.98.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.41.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 16 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.57
EARNINGS PER SHARE (EPS) AVG TTM
-1.98
EARNINGS PER SHARE (EPS) AVG 3Y
-2.34
EARNINGS PER SHARE (EPS) AVG 5Y
-2.63
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+20.91%
CURRENT VS 3Y AVG
+32.83%
CURRENT VS 5Y AVG
+40.39%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Relay Therapeutics, Inc.
Market Cap
$4.02B
Earnings Per Share (EPS)
-1.57
TTM Avg
-1.98
3Y Avg
-2.34
5Y Avg
-2.63
Market Cap
$4.03B
Earnings Per Share (EPS)
-0.54
TTM Avg
-0.52
3Y Avg
-0.25
5Y Avg
0.00
Market Cap
$3.97B
Earnings Per Share (EPS)
1.18
TTM Avg
-2.40
3Y Avg
-2.29
5Y Avg
-0.02
Market Cap
$4.14B
Earnings Per Share (EPS)
3.39
TTM Avg
-1.64
3Y Avg
-1.14
5Y Avg
-2.38
Market Cap
$3.81B
Earnings Per Share (EPS)
N/A
TTM Avg
-0.01
3Y Avg
-0.01
5Y Avg
-0.01
Market Cap
$4.31B
Earnings Per Share (EPS)
-1.85
TTM Avg
-1.54
3Y Avg
-1.48
5Y Avg
-1.19
Market Cap
$4.39B
Earnings Per Share (EPS)
-0.41
TTM Avg
-0.74
3Y Avg
-1.01
5Y Avg
-1.11
Market Cap
$4.43B
Earnings Per Share (EPS)
2.79
TTM Avg
0.85
3Y Avg
0.10
5Y Avg
0.11
Market Cap
$4.46B
Earnings Per Share (EPS)
-1.42
TTM Avg
-1.45
3Y Avg
-1.45
5Y Avg
-1.45
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Relay Therapeutics, Inc. (RLAY) | $4.02B | -1.57 | -1.98 | -2.34 | -2.63 |
| AbCellera Biologics Inc. (ABCL)vs › | $4.03B | -0.54 | -0.52 | -0.25 | 0.00 |
| ICU Medical, Inc. (ICUI)vs › | $3.97B | 1.18 | -2.40 | -2.29 | -0.02 |
| LivaNova PLC (LIVN)vs › | $4.14B | 3.39 | -1.64 | -1.14 | -2.38 |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.81B | N/A | -0.01 | -0.01 | -0.01 |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.31B | -1.85 | -1.54 | -1.48 | -1.19 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.39B | -0.41 | -0.74 | -1.01 | -1.11 |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.43B | 2.79 | 0.85 | 0.10 | 0.11 |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.46B | -1.42 | -1.45 | -1.45 | -1.45 |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.56B | -0.43 | -2.51 | -3.24 | -3.00 |
Trailing EPS (TTM)
$-1.57
Forward EPS (Est.)
$-1.60
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.61 |
| 2024-12-31 | -2.36 |
| 2023-12-31 | -2.79 |
| 2022-12-31 | -2.59 |
| 2021-12-31 | -3.82 |
| 2019-12-31 | -15.53 |
| 2018-12-31 | -19.63 |
